Cello World Limited (CELLO.NS) Stock Competitors & Peer Comparison
See (CELLO.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Furnishings, Fixtures & Appliances Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CELLO.NS | ₹368.65 | +2.83% | 81.4B | 25.69 | ₹14.35 | +0.41% |
| AMBER.BO | ₹7,780.80 | +2.47% | 274.7B | 61.77 | ₹125.96 | N/A |
| AMBER.NS | ₹7,779.00 | +2.35% | 274.3B | 93.24 | ₹83.43 | N/A |
| ASAHIINDIA.NS | ₹914.90 | +2.62% | 233.2B | 67.12 | ₹13.63 | +0.22% |
| CROMPTON.BO | ₹261.65 | +1.04% | 168.7B | 34.38 | ₹7.61 | +1.15% |
| CROMPTON.NS | ₹261.70 | +1.04% | 168.5B | 28.76 | ₹9.10 | +1.15% |
| WHIRLPOOL.BO | ₹795.15 | +0.33% | 100.9B | 35.50 | ₹22.40 | +0.63% |
| WHIRLPOOL.NS | ₹795.15 | +0.39% | 100.9B | 35.50 | ₹22.40 | +0.63% |
| EUREKAFORB.BO | ₹452.80 | +0.08% | 88.1B | 60.70 | ₹7.46 | N/A |
| EUREKAFORB.NS | ₹452.30 | +0.09% | 87.5B | 96.23 | ₹4.70 | N/A |
Stock Comparison
CELLO.NS vs AMBER.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, AMBER.BO has a market cap of 274.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while AMBER.BO trades at ₹7,780.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas AMBER.BO's P/E ratio is 61.77. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to AMBER.BO's ROE of +0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to AMBER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check AMBER.BO's competition here
CELLO.NS vs AMBER.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, AMBER.NS has a market cap of 274.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while AMBER.NS trades at ₹7,779.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas AMBER.NS's P/E ratio is 93.24. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to AMBER.NS's ROE of +0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to AMBER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check AMBER.NS's competition here
CELLO.NS vs ASAHIINDIA.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, ASAHIINDIA.NS has a market cap of 233.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while ASAHIINDIA.NS trades at ₹914.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas ASAHIINDIA.NS's P/E ratio is 67.12. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to ASAHIINDIA.NS's ROE of +0.10%. Regarding short-term risk, CELLO.NS is more volatile compared to ASAHIINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check ASAHIINDIA.NS's competition here
CELLO.NS vs CROMPTON.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CROMPTON.BO has a market cap of 168.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CROMPTON.BO trades at ₹261.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CROMPTON.BO's P/E ratio is 34.38. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CROMPTON.BO's ROE of -0.07%. Regarding short-term risk, CELLO.NS is more volatile compared to CROMPTON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CROMPTON.BO's competition here
CELLO.NS vs CROMPTON.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CROMPTON.NS has a market cap of 168.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CROMPTON.NS trades at ₹261.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CROMPTON.NS's P/E ratio is 28.76. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CROMPTON.NS's ROE of -0.07%. Regarding short-term risk, CELLO.NS is more volatile compared to CROMPTON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CROMPTON.NS's competition here
CELLO.NS vs WHIRLPOOL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WHIRLPOOL.BO has a market cap of 100.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WHIRLPOOL.BO trades at ₹795.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WHIRLPOOL.BO's P/E ratio is 35.50. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WHIRLPOOL.BO's ROE of +0.07%. Regarding short-term risk, CELLO.NS is more volatile compared to WHIRLPOOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check WHIRLPOOL.BO's competition here
CELLO.NS vs WHIRLPOOL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WHIRLPOOL.NS has a market cap of 100.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WHIRLPOOL.NS trades at ₹795.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WHIRLPOOL.NS's P/E ratio is 35.50. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WHIRLPOOL.NS's ROE of +0.07%. Regarding short-term risk, CELLO.NS is more volatile compared to WHIRLPOOL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check WHIRLPOOL.NS's competition here
CELLO.NS vs EUREKAFORB.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, EUREKAFORB.BO has a market cap of 88.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while EUREKAFORB.BO trades at ₹452.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas EUREKAFORB.BO's P/E ratio is 60.70. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to EUREKAFORB.BO's ROE of +0.04%. Regarding short-term risk, CELLO.NS is more volatile compared to EUREKAFORB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check EUREKAFORB.BO's competition here
CELLO.NS vs EUREKAFORB.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, EUREKAFORB.NS has a market cap of 87.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while EUREKAFORB.NS trades at ₹452.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas EUREKAFORB.NS's P/E ratio is 96.23. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to EUREKAFORB.NS's ROE of +0.04%. Regarding short-term risk, CELLO.NS is more volatile compared to EUREKAFORB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check EUREKAFORB.NS's competition here
CELLO.NS vs TTKPRESTIG.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, TTKPRESTIG.NS has a market cap of 86.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while TTKPRESTIG.NS trades at ₹631.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas TTKPRESTIG.NS's P/E ratio is 48.18. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to TTKPRESTIG.NS's ROE of +0.08%. Regarding short-term risk, CELLO.NS is more volatile compared to TTKPRESTIG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check TTKPRESTIG.NS's competition here
CELLO.NS vs TTKPRESTIG.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, TTKPRESTIG.BO has a market cap of 86.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while TTKPRESTIG.BO trades at ₹631.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas TTKPRESTIG.BO's P/E ratio is 48.21. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to TTKPRESTIG.BO's ROE of +0.08%. Regarding short-term risk, CELLO.NS is more volatile compared to TTKPRESTIG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check TTKPRESTIG.BO's competition here
CELLO.NS vs SFL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SFL.NS has a market cap of 83.6B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SFL.NS trades at ₹765.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SFL.NS's P/E ratio is 52.10. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SFL.NS's ROE of +0.05%. Regarding short-term risk, CELLO.NS is less volatile compared to SFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SFL.NS's competition here
CELLO.NS vs SFL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SFL.BO has a market cap of 83.6B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SFL.BO trades at ₹765.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SFL.BO's P/E ratio is 52.11. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SFL.BO's ROE of +0.05%. Regarding short-term risk, CELLO.NS is less volatile compared to SFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SFL.BO's competition here
CELLO.NS vs AVL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, AVL.NS has a market cap of 82.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while AVL.NS trades at ₹635.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas AVL.NS's P/E ratio is 130.29. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to AVL.NS's ROE of +0.18%. Regarding short-term risk, CELLO.NS is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check AVL.NS's competition here
CELLO.NS vs CELLO.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CELLO.BO has a market cap of 81.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CELLO.BO trades at ₹368.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CELLO.BO's P/E ratio is 25.70. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CELLO.BO's ROE of +0.13%. Regarding short-term risk, CELLO.NS is more volatile compared to CELLO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CELLO.BO's competition here
CELLO.NS vs CERA.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CERA.NS has a market cap of 81.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CERA.NS trades at ₹6,313.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CERA.NS's P/E ratio is 39.86. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CERA.NS's ROE of +0.15%. Regarding short-term risk, CELLO.NS is more volatile compared to CERA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CERA.NS's competition here
CELLO.NS vs GREENLAM.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GREENLAM.NS has a market cap of 65.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GREENLAM.NS trades at ₹257.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GREENLAM.NS's P/E ratio is 81.60. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GREENLAM.NS's ROE of +0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to GREENLAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GREENLAM.NS's competition here
CELLO.NS vs GREENLAM.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GREENLAM.BO has a market cap of 65.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GREENLAM.BO trades at ₹257.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GREENLAM.BO's P/E ratio is 32.78. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GREENLAM.BO's ROE of +0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to GREENLAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GREENLAM.BO's competition here
CELLO.NS vs IFBIND.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, IFBIND.BO has a market cap of 56B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while IFBIND.BO trades at ₹1,380.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas IFBIND.BO's P/E ratio is 39.95. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to IFBIND.BO's ROE of +0.15%. Regarding short-term risk, CELLO.NS is less volatile compared to IFBIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check IFBIND.BO's competition here
CELLO.NS vs IFBIND.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, IFBIND.NS has a market cap of 55.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while IFBIND.NS trades at ₹1,380.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas IFBIND.NS's P/E ratio is 39.96. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to IFBIND.NS's ROE of +0.15%. Regarding short-term risk, CELLO.NS is less volatile compared to IFBIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check IFBIND.NS's competition here
CELLO.NS vs STYLAMIND.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, STYLAMIND.BO has a market cap of 55.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while STYLAMIND.BO trades at ₹3,285.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas STYLAMIND.BO's P/E ratio is 37.15. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to STYLAMIND.BO's ROE of +0.21%. Regarding short-term risk, CELLO.NS is less volatile compared to STYLAMIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check STYLAMIND.BO's competition here
CELLO.NS vs STYLAMIND.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, STYLAMIND.NS has a market cap of 55.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while STYLAMIND.NS trades at ₹3,284.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas STYLAMIND.NS's P/E ratio is 37.22. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to STYLAMIND.NS's ROE of +0.21%. Regarding short-term risk, CELLO.NS is less volatile compared to STYLAMIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check STYLAMIND.NS's competition here
CELLO.NS vs SYMPHONY.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SYMPHONY.NS has a market cap of 49.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SYMPHONY.NS trades at ₹720.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SYMPHONY.NS's P/E ratio is 27.73. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SYMPHONY.NS's ROE of -0.19%. Regarding short-term risk, CELLO.NS is less volatile compared to SYMPHONY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SYMPHONY.NS's competition here
CELLO.NS vs SYMPHONY.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SYMPHONY.BO has a market cap of 49.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SYMPHONY.BO trades at ₹720.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SYMPHONY.BO's P/E ratio is 41.91. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SYMPHONY.BO's ROE of -0.19%. Regarding short-term risk, CELLO.NS is less volatile compared to SYMPHONY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SYMPHONY.BO's competition here
CELLO.NS vs WAKEFIT.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WAKEFIT.NS has a market cap of 43B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WAKEFIT.NS trades at ₹129.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WAKEFIT.NS's P/E ratio is 21.63. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WAKEFIT.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is less volatile compared to WAKEFIT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check WAKEFIT.NS's competition here
CELLO.NS vs JCHAC.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, JCHAC.NS has a market cap of 38.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while JCHAC.NS trades at ₹1,432.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas JCHAC.NS's P/E ratio is 138.91. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to JCHAC.NS's ROE of +0.02%. Regarding short-term risk, CELLO.NS is more volatile compared to JCHAC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check JCHAC.NS's competition here
CELLO.NS vs JCHAC.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, JCHAC.BO has a market cap of 38.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while JCHAC.BO trades at ₹1,427.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas JCHAC.BO's P/E ratio is 137.83. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to JCHAC.BO's ROE of +0.02%. Regarding short-term risk, CELLO.NS is more volatile compared to JCHAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check JCHAC.BO's competition here
CELLO.NS vs BAJAJELEC.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BAJAJELEC.BO has a market cap of 38.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BAJAJELEC.BO trades at ₹331.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BAJAJELEC.BO's P/E ratio is -163.28. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BAJAJELEC.BO's ROE of -0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to BAJAJELEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BAJAJELEC.BO's competition here
CELLO.NS vs BAJAJELEC.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BAJAJELEC.NS has a market cap of 38.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BAJAJELEC.NS trades at ₹331.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BAJAJELEC.NS's P/E ratio is -163.10. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BAJAJELEC.NS's ROE of -0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to BAJAJELEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BAJAJELEC.NS's competition here
CELLO.NS vs ORIENTELEC.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, ORIENTELEC.NS has a market cap of 38.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while ORIENTELEC.NS trades at ₹178.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas ORIENTELEC.NS's P/E ratio is 29.99. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to ORIENTELEC.NS's ROE of +0.13%. Regarding short-term risk, CELLO.NS is less volatile compared to ORIENTELEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check ORIENTELEC.NS's competition here
CELLO.NS vs ORIENTELEC.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, ORIENTELEC.BO has a market cap of 38.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while ORIENTELEC.BO trades at ₹178.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas ORIENTELEC.BO's P/E ratio is 39.37. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to ORIENTELEC.BO's ROE of +0.13%. Regarding short-term risk, CELLO.NS is less volatile compared to ORIENTELEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check ORIENTELEC.BO's competition here
CELLO.NS vs BOSCH-HCIL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BOSCH-HCIL.NS has a market cap of 36.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BOSCH-HCIL.NS trades at ₹1,348.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BOSCH-HCIL.NS's P/E ratio is 168.56. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BOSCH-HCIL.NS's ROE of -0.01%. Regarding short-term risk, CELLO.NS is more volatile compared to BOSCH-HCIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BOSCH-HCIL.NS's competition here
CELLO.NS vs BOSCH-HCIL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BOSCH-HCIL.BO has a market cap of 36.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BOSCH-HCIL.BO trades at ₹1,339.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BOSCH-HCIL.BO's P/E ratio is 167.46. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BOSCH-HCIL.BO's ROE of -0.01%. Regarding short-term risk, CELLO.NS is more volatile compared to BOSCH-HCIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BOSCH-HCIL.BO's competition here
CELLO.NS vs CARYSIL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CARYSIL.BO has a market cap of 33.6B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CARYSIL.BO trades at ₹1,178.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CARYSIL.BO's P/E ratio is 33.86. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CARYSIL.BO's ROE of +0.17%. Regarding short-term risk, CELLO.NS is less volatile compared to CARYSIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check CARYSIL.BO's competition here
CELLO.NS vs CARYSIL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CARYSIL.NS has a market cap of 33.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CARYSIL.NS trades at ₹1,173.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CARYSIL.NS's P/E ratio is 36.94. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CARYSIL.NS's ROE of +0.17%. Regarding short-term risk, CELLO.NS is less volatile compared to CARYSIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check CARYSIL.NS's competition here
CELLO.NS vs BOROLTD.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BOROLTD.BO has a market cap of 27.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BOROLTD.BO trades at ₹232.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BOROLTD.BO's P/E ratio is 37.14. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BOROLTD.BO's ROE of +0.09%. Regarding short-term risk, CELLO.NS is more volatile compared to BOROLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BOROLTD.BO's competition here
CELLO.NS vs BOROLTD.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BOROLTD.NS has a market cap of 27.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BOROLTD.NS trades at ₹231.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BOROLTD.NS's P/E ratio is 37.12. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BOROLTD.NS's ROE of +0.09%. Regarding short-term risk, CELLO.NS is more volatile compared to BOROLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check BOROLTD.NS's competition here
CELLO.NS vs STOVEKRAFT.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, STOVEKRAFT.NS has a market cap of 26.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while STOVEKRAFT.NS trades at ₹798.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas STOVEKRAFT.NS's P/E ratio is 62.42. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to STOVEKRAFT.NS's ROE of +0.09%. Regarding short-term risk, CELLO.NS is less volatile compared to STOVEKRAFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check STOVEKRAFT.NS's competition here
CELLO.NS vs STOVEKRAFT.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, STOVEKRAFT.BO has a market cap of 26.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while STOVEKRAFT.BO trades at ₹797.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas STOVEKRAFT.BO's P/E ratio is 62.34. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to STOVEKRAFT.BO's ROE of +0.09%. Regarding short-term risk, CELLO.NS is less volatile compared to STOVEKRAFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check STOVEKRAFT.BO's competition here
CELLO.NS vs EPACK.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, EPACK.NS has a market cap of 22.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while EPACK.NS trades at ₹233.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas EPACK.NS's P/E ratio is 121.98. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to EPACK.NS's ROE of +0.00%. Regarding short-term risk, CELLO.NS is more volatile compared to EPACK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check EPACK.NS's competition here
CELLO.NS vs LAOPALA.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, LAOPALA.NS has a market cap of 19.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while LAOPALA.NS trades at ₹179.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas LAOPALA.NS's P/E ratio is 21.41. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to LAOPALA.NS's ROE of +0.11%. Regarding short-term risk, CELLO.NS is more volatile compared to LAOPALA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check LAOPALA.NS's competition here
CELLO.NS vs LAOPALA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, LAOPALA.BO has a market cap of 19.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while LAOPALA.BO trades at ₹178.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas LAOPALA.BO's P/E ratio is 21.29. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to LAOPALA.BO's ROE of +0.11%. Regarding short-term risk, CELLO.NS is more volatile compared to LAOPALA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check LAOPALA.BO's competition here
CELLO.NS vs NILKAMAL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, NILKAMAL.NS has a market cap of 19.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while NILKAMAL.NS trades at ₹1,303.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas NILKAMAL.NS's P/E ratio is 17.31. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to NILKAMAL.NS's ROE of +0.08%. Regarding short-term risk, CELLO.NS is more volatile compared to NILKAMAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check NILKAMAL.NS's competition here
CELLO.NS vs NILKAMAL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, NILKAMAL.BO has a market cap of 19.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while NILKAMAL.BO trades at ₹1,304.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas NILKAMAL.BO's P/E ratio is 17.16. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to NILKAMAL.BO's ROE of +0.08%. Regarding short-term risk, CELLO.NS is more volatile compared to NILKAMAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check NILKAMAL.BO's competition here
CELLO.NS vs WEL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WEL.NS has a market cap of 13.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WEL.NS trades at ₹102.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WEL.NS's P/E ratio is 150.90. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WEL.NS's ROE of +0.09%. Regarding short-term risk, CELLO.NS is less volatile compared to WEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check WEL.NS's competition here
CELLO.NS vs WEL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WEL.BO has a market cap of 13.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WEL.BO trades at ₹102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WEL.BO's P/E ratio is 78.94. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WEL.BO's ROE of +0.09%. Regarding short-term risk, CELLO.NS is less volatile compared to WEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check WEL.BO's competition here
CELLO.NS vs GRNLAMIND.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GRNLAMIND.BO has a market cap of 13.4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GRNLAMIND.BO trades at ₹556.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GRNLAMIND.BO's P/E ratio is 19.03. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GRNLAMIND.BO's ROE of -0.01%. Regarding short-term risk, CELLO.NS is more volatile compared to GRNLAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GRNLAMIND.BO's competition here
CELLO.NS vs BUTTERFLY.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BUTTERFLY.NS has a market cap of 13.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BUTTERFLY.NS trades at ₹731.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BUTTERFLY.NS's P/E ratio is 28.83. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BUTTERFLY.NS's ROE of +0.13%. Regarding short-term risk, CELLO.NS is less volatile compared to BUTTERFLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check BUTTERFLY.NS's competition here
CELLO.NS vs BUTTERFLY.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BUTTERFLY.BO has a market cap of 13.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BUTTERFLY.BO trades at ₹731.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BUTTERFLY.BO's P/E ratio is 28.64. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BUTTERFLY.BO's ROE of +0.13%. Regarding short-term risk, CELLO.NS is less volatile compared to BUTTERFLY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check BUTTERFLY.BO's competition here
CELLO.NS vs MIRCELECTR.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, MIRCELECTR.BO has a market cap of 13B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while MIRCELECTR.BO trades at ₹42.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas MIRCELECTR.BO's P/E ratio is -62.00. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to MIRCELECTR.BO's ROE of -0.46%. Regarding short-term risk, CELLO.NS is more volatile compared to MIRCELECTR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check MIRCELECTR.BO's competition here
CELLO.NS vs ROBU.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, ROBU.BO has a market cap of 12.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while ROBU.BO trades at ₹1,169.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas ROBU.BO's P/E ratio is 413.20. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to ROBU.BO's ROE of +0.31%. Regarding short-term risk, CELLO.NS is less volatile compared to ROBU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check ROBU.BO's competition here
CELLO.NS vs MIRCELECTR.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, MIRCELECTR.NS has a market cap of 11.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while MIRCELECTR.NS trades at ₹42.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas MIRCELECTR.NS's P/E ratio is -17.45. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to MIRCELECTR.NS's ROE of -0.46%. Regarding short-term risk, CELLO.NS is less volatile compared to MIRCELECTR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check MIRCELECTR.NS's competition here
CELLO.NS vs SAINTGOBAIN.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SAINTGOBAIN.BO has a market cap of 10.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SAINTGOBAIN.BO trades at ₹113.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SAINTGOBAIN.BO's P/E ratio is 28.70. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SAINTGOBAIN.BO's ROE of +0.10%. Regarding short-term risk, CELLO.NS is more volatile compared to SAINTGOBAIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check SAINTGOBAIN.BO's competition here
CELLO.NS vs STANLEY.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, STANLEY.NS has a market cap of 8.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while STANLEY.NS trades at ₹156.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas STANLEY.NS's P/E ratio is 73.68. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to STANLEY.NS's ROE of +0.03%. Regarding short-term risk, CELLO.NS is more volatile compared to STANLEY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check STANLEY.NS's competition here
CELLO.NS vs PARIN.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PARIN.NS has a market cap of 8.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PARIN.NS trades at ₹715.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PARIN.NS's P/E ratio is 106.52. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PARIN.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is less volatile compared to PARIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check PARIN.NS's competition here
CELLO.NS vs CELLECOR.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CELLECOR.NS has a market cap of 8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CELLECOR.NS trades at ₹38.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CELLECOR.NS's P/E ratio is 26.38. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CELLECOR.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is more volatile compared to CELLECOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CELLECOR.NS's competition here
CELLO.NS vs FOCUS.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, FOCUS.NS has a market cap of 5.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while FOCUS.NS trades at ₹81.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas FOCUS.NS's P/E ratio is 105.82. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to FOCUS.NS's ROE of +0.04%. Regarding short-term risk, CELLO.NS is less volatile compared to FOCUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check FOCUS.NS's competition here
CELLO.NS vs RUSHIL.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, RUSHIL.NS has a market cap of 4.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while RUSHIL.NS trades at ₹16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas RUSHIL.NS's P/E ratio is 73.27. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to RUSHIL.NS's ROE of +0.01%. Regarding short-term risk, CELLO.NS is more volatile compared to RUSHIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check RUSHIL.NS's competition here
CELLO.NS vs RUSHIL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, RUSHIL.BO has a market cap of 4.7B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while RUSHIL.BO trades at ₹16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas RUSHIL.BO's P/E ratio is 34.28. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to RUSHIL.BO's ROE of +0.01%. Regarding short-term risk, CELLO.NS is more volatile compared to RUSHIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check RUSHIL.BO's competition here
CELLO.NS vs SINGER.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SINGER.BO has a market cap of 4.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SINGER.BO trades at ₹68.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SINGER.BO's P/E ratio is 38.90. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SINGER.BO's ROE of +0.08%. Regarding short-term risk, CELLO.NS is less volatile compared to SINGER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SINGER.BO's competition here
CELLO.NS vs UNIVPHOTO.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, UNIVPHOTO.BO has a market cap of 4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while UNIVPHOTO.BO trades at ₹372.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas UNIVPHOTO.BO's P/E ratio is -5.10. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to UNIVPHOTO.BO's ROE of -0.09%. Regarding short-term risk, CELLO.NS is less volatile compared to UNIVPHOTO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check UNIVPHOTO.BO's competition here
CELLO.NS vs WIMPLAST.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, WIMPLAST.BO has a market cap of 4B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while WIMPLAST.BO trades at ₹334.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas WIMPLAST.BO's P/E ratio is 6.61. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to WIMPLAST.BO's ROE of +0.11%. Regarding short-term risk, CELLO.NS is less volatile compared to WIMPLAST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check WIMPLAST.BO's competition here
CELLO.NS vs UNIVPHOTO.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, UNIVPHOTO.NS has a market cap of 3.8B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while UNIVPHOTO.NS trades at ₹350.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas UNIVPHOTO.NS's P/E ratio is -4.57. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to UNIVPHOTO.NS's ROE of -0.09%. Regarding short-term risk, CELLO.NS is more volatile compared to UNIVPHOTO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check UNIVPHOTO.NS's competition here
CELLO.NS vs BELLACASA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BELLACASA.BO has a market cap of 3.6B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BELLACASA.BO trades at ₹264.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BELLACASA.BO's P/E ratio is 31.70. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BELLACASA.BO's ROE of +0.13%. Regarding short-term risk, CELLO.NS is less volatile compared to BELLACASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check BELLACASA.BO's competition here
CELLO.NS vs BHATIA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, BHATIA.BO has a market cap of 3.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while BHATIA.BO trades at ₹24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas BHATIA.BO's P/E ratio is 29.53. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to BHATIA.BO's ROE of +0.16%. Regarding short-term risk, CELLO.NS is less volatile compared to BHATIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check BHATIA.BO's competition here
CELLO.NS vs VIDEOIND.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, VIDEOIND.NS has a market cap of 2.5B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while VIDEOIND.NS trades at ₹7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas VIDEOIND.NS's P/E ratio is -0.03. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to VIDEOIND.NS's ROE of +0.28%. Regarding short-term risk, CELLO.NS is less volatile compared to VIDEOIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check VIDEOIND.NS's competition here
CELLO.NS vs SONAMLTD.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SONAMLTD.NS has a market cap of 2.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SONAMLTD.NS trades at ₹54.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SONAMLTD.NS's P/E ratio is 33.81. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SONAMLTD.NS's ROE of +0.10%. Regarding short-term risk, CELLO.NS is less volatile compared to SONAMLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SONAMLTD.NS's competition here
CELLO.NS vs PILITA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PILITA.BO has a market cap of 2.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PILITA.BO trades at ₹8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PILITA.BO's P/E ratio is 47.44. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PILITA.BO's ROE of +0.06%. Regarding short-term risk, CELLO.NS is less volatile compared to PILITA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check PILITA.BO's competition here
CELLO.NS vs PILITA.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PILITA.NS has a market cap of 2.1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PILITA.NS trades at ₹8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PILITA.NS's P/E ratio is 47.39. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PILITA.NS's ROE of +0.06%. Regarding short-term risk, CELLO.NS is less volatile compared to PILITA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check PILITA.NS's competition here
CELLO.NS vs INFLAME.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, INFLAME.BO has a market cap of 1.9B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while INFLAME.BO trades at ₹251.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas INFLAME.BO's P/E ratio is 32.19. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to INFLAME.BO's ROE of +0.10%. Regarding short-term risk, CELLO.NS is less volatile compared to INFLAME.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check INFLAME.BO's competition here
CELLO.NS vs SONAMCLOCK.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SONAMCLOCK.NS has a market cap of 1.6B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SONAMCLOCK.NS trades at ₹81.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SONAMCLOCK.NS's P/E ratio is 40.88. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SONAMCLOCK.NS's ROE of +0.08%. Regarding short-term risk, CELLO.NS is less volatile compared to SONAMCLOCK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SONAMCLOCK.NS's competition here
CELLO.NS vs PRIMAPLA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PRIMAPLA.BO has a market cap of 1.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PRIMAPLA.BO trades at ₹119.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PRIMAPLA.BO's P/E ratio is 7.07. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PRIMAPLA.BO's ROE of +0.10%. Regarding short-term risk, CELLO.NS is less volatile compared to PRIMAPLA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check PRIMAPLA.BO's competition here
CELLO.NS vs AVROIND.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, AVROIND.NS has a market cap of 1.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while AVROIND.NS trades at ₹9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas AVROIND.NS's P/E ratio is 28.54. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to AVROIND.NS's ROE of +0.05%. Regarding short-term risk, CELLO.NS is less volatile compared to AVROIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check AVROIND.NS's competition here
CELLO.NS vs AVROIND.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, AVROIND.BO has a market cap of 1.3B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while AVROIND.BO trades at ₹9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas AVROIND.BO's P/E ratio is 28.43. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to AVROIND.BO's ROE of +0.05%. Regarding short-term risk, CELLO.NS is less volatile compared to AVROIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check AVROIND.BO's competition here
CELLO.NS vs GREENCHEF.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GREENCHEF.NS has a market cap of 1.2B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GREENCHEF.NS trades at ₹50.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GREENCHEF.NS's P/E ratio is 19.75. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GREENCHEF.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is more volatile compared to GREENCHEF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GREENCHEF.NS's competition here
CELLO.NS vs TEXELIN.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, TEXELIN.BO has a market cap of 1B. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while TEXELIN.BO trades at ₹72.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas TEXELIN.BO's P/E ratio is 20.74. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to TEXELIN.BO's ROE of +0.11%. Regarding short-term risk, CELLO.NS is less volatile compared to TEXELIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check TEXELIN.BO's competition here
CELLO.NS vs SPITZE.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SPITZE.BO has a market cap of 845.3M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SPITZE.BO trades at ₹56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SPITZE.BO's P/E ratio is 28.57. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SPITZE.BO's ROE of +0.25%. Regarding short-term risk, CELLO.NS is less volatile compared to SPITZE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SPITZE.BO's competition here
CELLO.NS vs FONEBOX.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, FONEBOX.NS has a market cap of 761.8M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while FONEBOX.NS trades at ₹74.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas FONEBOX.NS's P/E ratio is 16.76. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to FONEBOX.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is less volatile compared to FONEBOX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check FONEBOX.NS's competition here
CELLO.NS vs NEWJAISA.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, NEWJAISA.NS has a market cap of 638.5M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while NEWJAISA.NS trades at ₹17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas NEWJAISA.NS's P/E ratio is -27.12. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to NEWJAISA.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is less volatile compared to NEWJAISA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check NEWJAISA.NS's competition here
CELLO.NS vs KHAITANLTD.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, KHAITANLTD.NS has a market cap of 622.3M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while KHAITANLTD.NS trades at ₹131.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas KHAITANLTD.NS's P/E ratio is -59.90. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to KHAITANLTD.NS's ROE of +0.20%. Regarding short-term risk, CELLO.NS is more volatile compared to KHAITANLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check KHAITANLTD.NS's competition here
CELLO.NS vs KHAITANLTD.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, KHAITANLTD.BO has a market cap of 612.7M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while KHAITANLTD.BO trades at ₹134.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas KHAITANLTD.BO's P/E ratio is -147.87. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to KHAITANLTD.BO's ROE of +0.20%. Regarding short-term risk, CELLO.NS is less volatile compared to KHAITANLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check KHAITANLTD.BO's competition here
CELLO.NS vs PULZ.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PULZ.NS has a market cap of 560.5M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PULZ.NS trades at ₹25.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PULZ.NS's P/E ratio is 48.49. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PULZ.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is more volatile compared to PULZ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check PULZ.NS's competition here
CELLO.NS vs PRITI.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PRITI.NS has a market cap of 534M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PRITI.NS trades at ₹39.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PRITI.NS's P/E ratio is 15.15. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PRITI.NS's ROE of +0.01%. Regarding short-term risk, CELLO.NS is less volatile compared to PRITI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check PRITI.NS's competition here
CELLO.NS vs SACHEMT.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SACHEMT.BO has a market cap of 480M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SACHEMT.BO trades at ₹3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SACHEMT.BO's P/E ratio is 14.77. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SACHEMT.BO's ROE of +0.04%. Regarding short-term risk, CELLO.NS is more volatile compared to SACHEMT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check SACHEMT.BO's competition here
CELLO.NS vs TIRUFOAM.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, TIRUFOAM.BO has a market cap of 323.1M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while TIRUFOAM.BO trades at ₹73.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas TIRUFOAM.BO's P/E ratio is 30.67. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to TIRUFOAM.BO's ROE of +0.06%. Regarding short-term risk, CELLO.NS is more volatile compared to TIRUFOAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check TIRUFOAM.BO's competition here
CELLO.NS vs GUJRAFIA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GUJRAFIA.BO has a market cap of 300.5M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GUJRAFIA.BO trades at ₹55.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GUJRAFIA.BO's P/E ratio is 94.24. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GUJRAFIA.BO's ROE of +0.02%. Regarding short-term risk, CELLO.NS is more volatile compared to GUJRAFIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GUJRAFIA.BO's competition here
CELLO.NS vs CELLPOINT.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, CELLPOINT.NS has a market cap of 295.2M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while CELLPOINT.NS trades at ₹15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas CELLPOINT.NS's P/E ratio is 13.28. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to CELLPOINT.NS's ROE of N/A. Regarding short-term risk, CELLO.NS is more volatile compared to CELLPOINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check CELLPOINT.NS's competition here
CELLO.NS vs MILEFUR.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, MILEFUR.BO has a market cap of 263.8M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while MILEFUR.BO trades at ₹28.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas MILEFUR.BO's P/E ratio is -70.95. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to MILEFUR.BO's ROE of -0.02%. Regarding short-term risk, CELLO.NS is more volatile compared to MILEFUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check MILEFUR.BO's competition here
CELLO.NS vs GORANIN.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GORANIN.BO has a market cap of 251.2M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GORANIN.BO trades at ₹46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GORANIN.BO's P/E ratio is 55.02. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GORANIN.BO's ROE of +0.05%. Regarding short-term risk, CELLO.NS is more volatile compared to GORANIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GORANIN.BO's competition here
CELLO.NS vs JAIPAN.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, JAIPAN.BO has a market cap of 225.6M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while JAIPAN.BO trades at ₹36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas JAIPAN.BO's P/E ratio is 67.25. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to JAIPAN.BO's ROE of +0.49%. Regarding short-term risk, CELLO.NS is less volatile compared to JAIPAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check JAIPAN.BO's competition here
CELLO.NS vs COMRADE.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, COMRADE.BO has a market cap of 204.2M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while COMRADE.BO trades at ₹26.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas COMRADE.BO's P/E ratio is -2.16. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to COMRADE.BO's ROE of -0.66%. Regarding short-term risk, CELLO.NS is more volatile compared to COMRADE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check COMRADE.BO's competition here
CELLO.NS vs JAIMATAG.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, JAIMATAG.BO has a market cap of 169M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while JAIMATAG.BO trades at ₹1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas JAIMATAG.BO's P/E ratio is -126.31. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to JAIMATAG.BO's ROE of -0.10%. Regarding short-term risk, CELLO.NS is less volatile compared to JAIMATAG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check JAIMATAG.BO's competition here
CELLO.NS vs APIL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, APIL.BO has a market cap of 157.2M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while APIL.BO trades at ₹47.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas APIL.BO's P/E ratio is -792.33. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to APIL.BO's ROE of -0.32%. Regarding short-term risk, CELLO.NS is more volatile compared to APIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check APIL.BO's competition here
CELLO.NS vs SEASONST.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, SEASONST.BO has a market cap of 123.6M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while SEASONST.BO trades at ₹16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas SEASONST.BO's P/E ratio is -53.14. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to SEASONST.BO's ROE of +0.00%. Regarding short-term risk, CELLO.NS is less volatile compared to SEASONST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check SEASONST.BO's competition here
CELLO.NS vs KUWERIN.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, KUWERIN.BO has a market cap of 105.9M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while KUWERIN.BO trades at ₹11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas KUWERIN.BO's P/E ratio is 8.28. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to KUWERIN.BO's ROE of +0.10%. Regarding short-term risk, CELLO.NS is less volatile compared to KUWERIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check KUWERIN.BO's competition here
CELLO.NS vs GOLCA.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, GOLCA.BO has a market cap of 81.5M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while GOLCA.BO trades at ₹12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas GOLCA.BO's P/E ratio is -50.20. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to GOLCA.BO's ROE of +1.01%. Regarding short-term risk, CELLO.NS is more volatile compared to GOLCA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check GOLCA.BO's competition here
CELLO.NS vs MPL.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, MPL.BO has a market cap of 78.4M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while MPL.BO trades at ₹6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas MPL.BO's P/E ratio is 30.14. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to MPL.BO's ROE of +0.04%. Regarding short-term risk, CELLO.NS is more volatile compared to MPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check MPL.BO's competition here
CELLO.NS vs PHOTOQUP.BO Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, PHOTOQUP.BO has a market cap of 78M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while PHOTOQUP.BO trades at ₹12.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas PHOTOQUP.BO's P/E ratio is -7.30. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to PHOTOQUP.BO's ROE of -0.11%. Regarding short-term risk, CELLO.NS is more volatile compared to PHOTOQUP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CELLO.NS.Check PHOTOQUP.BO's competition here
CELLO.NS vs JIKIND.NS Comparison July 2026
CELLO.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CELLO.NS stands at 81.4B. In comparison, JIKIND.NS has a market cap of 47.2M. Regarding current trading prices, CELLO.NS is priced at ₹368.65, while JIKIND.NS trades at ₹0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CELLO.NS currently has a P/E ratio of 25.69, whereas JIKIND.NS's P/E ratio is -26.00. In terms of profitability, CELLO.NS's ROE is +0.13%, compared to JIKIND.NS's ROE of +0.00%. Regarding short-term risk, CELLO.NS is less volatile compared to JIKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CELLO.NS.Check JIKIND.NS's competition here